Overview

A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia

Status:
Completed
Trial end date:
2012-10-22
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared with placebo for the treatment of iron deficiency anemia (IDA).
Phase:
Phase 3
Details
Lead Sponsor:
AMAG Pharmaceuticals, Inc.
Treatments:
Ferrosoferric Oxide
Iron